van Marcke C - Search Results

1

Routine use of gene panel testing in hereditary breast cancer should be performed with caution.

van Marcke C, De Leener A, Berlière M, Vikkula M, Duhoux FP. van Marcke C, et al. Crit Rev Oncol Hematol. 2016 Dec;108:33-39. doi: 10.1016/j.critrevonc.2016.10.008. Epub 2016 Oct 29. Crit Rev Oncol Hematol. 2016. PMID: 27931838 Review.

2

Comment on "Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing".

van Marcke C, Vikkula M, Duhoux FP. van Marcke C, et al. J Am Coll Radiol. 2017 May;14(5):582. doi: 10.1016/j.jacr.2017.01.017. J Am Coll Radiol. 2017. PMID: 28473152 No abstract available.

3

Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data.

van Marcke C, Collard A, Vikkula M, Duhoux FP. van Marcke C, et al. Crit Rev Oncol Hematol. 2018 Dec;132:138-144. doi: 10.1016/j.critrevonc.2018.09.009. Epub 2018 Sep 14. Crit Rev Oncol Hematol. 2018. PMID: 30447919

4

Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma.

Galot R, van Marcke C, Helaers R, Mendola A, Goebbels RM, Caignet X, Ambroise J, Wittouck K, Vikkula M, Limaye N, Machiels JH. Galot R, et al. Among authors: van marcke c. Oral Oncol. 2020 May;104:104631. doi: 10.1016/j.oraloncology.2020.104631. Epub 2020 Mar 10. Oral Oncol. 2020. PMID: 32169746

5

Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.

Van Marcke C, Helaers R, De Leener A, Merhi A, Schoonjans CA, Ambroise J, Galant C, Delrée P, Rothé F, Bar I, Khoury E, Brouillard P, Canon JL, Vuylsteke P, Machiels JP, Berlière M, Limaye N, Vikkula M, Duhoux FP. Van Marcke C, et al. Breast Cancer Res. 2020 Apr 15;22(1):36. doi: 10.1186/s13058-020-01273-y. Breast Cancer Res. 2020. PMID: 32295625 Free PMC article.

6

Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer.

Van Bockstal MR, Noel F, Guiot Y, Duhoux FP, Mazzeo F, Van Marcke C, Fellah L, Ledoux B, Berlière M, Galant C. Van Bockstal MR, et al. Among authors: van marcke c. Ann Diagn Pathol. 2020 Dec;49:151634. doi: 10.1016/j.anndiagpath.2020.151634. Epub 2020 Sep 19. Ann Diagn Pathol. 2020. PMID: 32987254

7

Tumor apelin and obesity are associated with reduced neoadjuvant chemotherapy response in a cohort of breast cancer patients.

Gourgue F, Derouane F, van Marcke C, Villar E, Dano H, Desmet L, Bouzin C, Duhoux FP, Cani PD, Jordan BF. Gourgue F, et al. Among authors: van marcke c. Sci Rep. 2021 May 10;11(1):9922. doi: 10.1038/s41598-021-89385-z. Sci Rep. 2021. PMID: 33972642 Free PMC article.

8

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.

van Marcke C, Honoré N, van der Elst A, Beyaert S, Derouane F, Dumont C, Aboubakar Nana F, Baurain JF, Borbath I, Collard P, Cornélis F, De Cuyper A, Duhoux FP, Filleul B, Galot R, Gizzi M, Mazzeo F, Pieters T, Seront E, Sinapi I, Van den Eynde M, Whenham N, Yombi JC, Scohy A, van Maanen A, Machiels JP. van Marcke C, et al. Among authors: van maanen a, van der elst a, van den eynde m. BMC Cancer. 2021 May 20;21(1):578. doi: 10.1186/s12885-021-08349-8. BMC Cancer. 2021. PMID: 34016086 Free PMC article.

9

PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.

Thouvenin J, Van Marcke C, Decoster L, Raicevic G, Punie K, Vandenbulcke M, Salgado R, Van Valckenborgh E, Maes B, Joris S, Steichel DV, Vranken K, Jacobs S, Dedeurwaerdere F, Martens G, Devos H, Duhoux FP, Rasschaert M, Pauwels P, Geboes K, Collignon J, Tejpar S, Canon JL, Peeters M, Rutten A, Van de Mooter T, Vermeij J, Schrijvers D, Demey W, Lybaert W, Van Huysse J, Mebis J, Awada A, Claes KBM, Hebrant A, Van der Meulen J, Delafontaine B, Bempt IV, Maetens J, de Hemptinne M, Rottey S, Aftimos P, De Grève J. Thouvenin J, et al. Among authors: van de mooter t, van der meulen j, van valckenborgh e, van huysse j, van marcke c. ESMO Open. 2022 Aug;7(4):100524. doi: 10.1016/j.esmoop.2022.100524. Epub 2022 Aug 12. ESMO Open. 2022. PMID: 35970014 Free PMC article.

10

Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine.

Derouane F, van Marcke C, Berlière M, Gerday A, Fellah L, Leconte I, Van Bockstal MR, Galant C, Corbet C, Duhoux FP. Derouane F, et al. Among authors: van bockstal mr, van marcke c. Cancers (Basel). 2022 Aug 11;14(16):3876. doi: 10.3390/cancers14163876. Cancers (Basel). 2022. PMID: 36010869 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page